Showing results (2001-2010 of 2,409) with videos related to
Sort By:
Pageof 241
The Journal of Biological Chemistry|May 20, 2004
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agentsAndrea Schweinitz, Torsten Steinmetzer, Ingo J Banke, et al.Leukemia|August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosisA Weltermann, I Pabinger, K Geissler, et al.Journal of Attention Disorders|February 11, 2014
Sex- and Subtype-Related Differences of Personality Disorders (Axis II) and Personality Traits in Persistent ADHDChristian P Jacob, Silke Gross-Lesch, Susanne Reichert, et al.Health Services Research|January 26, 2013
Resource use trajectories for aged medicare beneficiaries with complex coronary conditionsJerome J Federspiel, Sally C Stearns, Laura P D'Arcy, et al.Attention Deficit and Hyperactivity Disorders|May 8, 2012
Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole bloodEdna Grünblatt, Julia Geissler, Christian P Jacob, et al.Gene Therapy|November 9, 2007
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinomaM J Willhauck, B R Sharif Samani, K Klutz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growthSven A Lang, Christian Moser, Andreas Gaumann, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 2, 2016
Functional Impact of An ADHD-Associated DIRAS2 Promoter PolymorphismLena Grünewald, Elisabeth Toverud Landaas, Julia Geissler, et al.Therapeutic Innovation & Regulatory Science|November 6, 2015
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for ActionAnton Hoos, James Anderson, Marc Boutin, et al.International Journal of Surgery (London, England)|April 25, 2025
Soluble CD46 improves detection of hepatic steatosis by contrast-enhanced computed tomography before liver surgeryPaul Kupke, Laura S Kupke, Gunther Glehr, et al.Pageof 241